Skip to content

Author

Long Cheng

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

CDKN3 in cancer: context-dependent cell-cycle control and implications for genome stability and therapy

Cyclin-dependent kinase inhibitor 3 (CDKN3), also known as kinase-associated phosphatase (KAP), dephosphorylates activating cyclin-dependent kinase 2 (CDK2) Thr160, yet high expression is associated with aggressive features in some cancers. This review distinguishes messenger RNA (mRNA) expression, protein abundance, p...

Yi Li, Long Cheng, Xiao-Wei Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.